Evonik resumed the production of methionine in Antwerp on November 26th. The company is pleased it solved the issue that caused the temporary shut down.
Dr. Emmanuel Auer, Head of Animal Nutrition Business Line at Evonik explained: “We are pleased that we could solve the issue and resume MetAmin production. We would like to thank our customers for the patience and support shown whilst we resolved the situation.”
Following an issue with hydrocyanic acid (HCN) supply for methionine production, Evonik had to temporarily shut down its methionine manufacturing plants in Antwerp early november. “Unfortunately we suffered an outage of HCN supply for our methionine production. The supply failure impacts both of our methionine plants in Antwerp.”
Evonik is one of the world leaders in specialty chemicals. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,200 employees, and generated sales of around €4.6 billion in 2018.